A detailed history of Oak Associates LTD transactions in Pfizer Inc stock. As of the latest transaction made, Oak Associates LTD holds 474,038 shares of PFE stock, worth $11.9 Million. This represents 0.92% of its overall portfolio holdings.

Number of Shares
474,038
Previous 299,470 58.29%
Holding current value
$11.9 Million
Previous $8.38 Million 63.72%
% of portfolio
0.92%
Previous 0.56%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$27.7 - $31.39 $4.84 Million - $5.48 Million
174,568 Added 58.29%
474,038 $13.7 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $421,320 - $547,248
-16,124 Reduced 5.11%
299,470 $8.62 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $90,686 - $106,003
-2,826 Reduced 0.89%
315,594 $10.5 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $100,919 - $116,761
-2,794 Reduced 0.87%
318,420 $11.7 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $1.2 Million - $1.56 Million
30,448 Added 10.47%
321,214 $13.1 Million
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $1.35 Million - $1.76 Million
-32,248 Reduced 9.98%
290,766 $14.9 Million
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $743 - $908
17 Added 0.01%
323,014 $14.1 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $695,437 - $824,570
14,946 Added 4.85%
322,997 $16.9 Million
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $1.09 Million - $1.36 Million
23,906 Added 8.41%
308,051 $15.9 Million
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $578 - $857
14 Added 0.0%
284,145 $16.8 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $628 - $806
16 Added 0.01%
284,131 $12.2 Million
Q2 2021

Aug 09, 2021

SELL
$35.91 - $40.68 $1.15 Million - $1.3 Million
-31,921 Reduced 10.1%
284,115 $11.1 Million
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $6.87 Million - $7.74 Million
-205,047 Reduced 39.35%
316,036 $11.5 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $1.52 Million - $1.93 Million
-45,386 Reduced 8.01%
521,083 $19.2 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $1.2 Million - $1.41 Million
-37,818 Reduced 6.26%
566,469 $20.8 Million
Q2 2020

Aug 11, 2020

SELL
$30.12 - $36.54 $327,374 - $397,153
-10,869 Reduced 1.77%
604,287 $19.8 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $1.42 Million - $2.03 Million
-52,478 Reduced 7.86%
615,156 $20.1 Million
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $701,689 - $796,328
-21,315 Reduced 3.09%
667,634 $26.2 Million
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $187,987 - $243,764
-5,786 Reduced 0.83%
688,949 $24.8 Million
Q2 2019

Aug 09, 2019

BUY
$36.98 - $41.52 $498,009 - $559,149
13,467 Added 1.98%
694,735 $30.1 Million
Q1 2019

May 09, 2019

SELL
$37.5 - $41.2 $809,812 - $889,714
-21,595 Reduced 3.07%
681,268 $28.9 Million
Q4 2018

Feb 07, 2019

BUY
$38.47 - $43.86 $134,760 - $153,641
3,503 Added 0.5%
702,863 $30.7 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $17 Million - $20.7 Million
493,910 Added 240.4%
699,360 $30.8 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $3,792 - $4,043
115 Added 0.06%
205,450 $7.45 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $5.44 Million - $6.32 Million
170,591 Added 490.99%
205,335 $7.29 Million
Q4 2017

Feb 08, 2018

BUY
$33.26 - $35.29 $1.16 Million - $1.23 Million
34,744
34,744 $1.26 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Oak Associates LTD Portfolio

Follow Oak Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Associates LTD , based on Form 13F filings with the SEC.

News

Stay updated on Oak Associates LTD with notifications on news.